BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33337841)

  • 21. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
    Lee WS; Singh G
    Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case report of biclonal immunoglobulin D lambda/lambda multiple myeloma in patient with liver echinococcosis.
    Prce A; Dunđerović Ž; Mikulić I; Mikulić V; Ljubić K; Ćuk A; Bogut A; Petrović J; Volarić M; Čolak T; Raguž F
    Biochem Med (Zagreb); 2024 Jun; 34(2):020801. PubMed ID: 38665868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflexing Suspicious β-Region Findings on Capillary Serum Protein Electrophoresis to Immunofixation or Immunosubtraction for Detecting Monoclonal Proteins.
    Kitson AL; Taylor AS; Giacherio DA; Keren DF
    Am J Clin Pathol; 2022 Feb; 157(2):171-179. PubMed ID: 34519791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case of the IgE prozone phenomenon in IgE multiple myeloma.
    Chae H; Kim H; Choi A; Oh EJ; Min CK
    Clin Biochem; 2022 Jun; 104():59-61. PubMed ID: 35131261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M-Proteins) in dogs with multiple myeloma and related disorders: Part 2-Toward improved diagnostic performance.
    Moore AR; Harris RA; Jeffries C; Ashton L; Avery PR
    Vet Clin Pathol; 2021 Jun; 50(2):249-258. PubMed ID: 33855710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of the Helena V8 capillary electrophoresis system.
    Poisson J; Fedoriw Y; Henderson MP; Hainsworth S; Tucker K; Uddin Z; McCudden CR
    Clin Biochem; 2012 Jun; 45(9):697-9. PubMed ID: 22465274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biclonal gammopathy of kappa light chain type in a case of multiple myeloma.
    Rabhi H; Ghaffor M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():141-50. PubMed ID: 2518743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological difficulties of a heavy chains disease diagnosis].
    Planté P; Hochart AC; Gressier B
    Ann Biol Clin (Paris); 2022 Feb; 80(1):75-79. PubMed ID: 35107066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods].
    Schneider N; Wynckel A; Kolb B; Sablon E; Gillery P; Maquart FX
    Ann Biol Clin (Paris); 2013; 71(1):13-9. PubMed ID: 23396425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.
    Miyazaki K; Suzuki K
    Amyloid; 2016 Dec; 23(4):221-224. PubMed ID: 27682970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
    Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.